Skip to nav Skip to content

Stay up-to-date with news and the latest in cancer care, created for and by healthcare professionals. MoffittBlog®

293 Stories Found

Expanding Minimally Invasive Options for Lung Metastases: The Role of Thermal Ablation

Moffitt Cancer Center has been working to expand access to thermal ablation for appropriate patients in the Southeast.

Doctor comforting a patient

6 Common Bone Marrow Transplant Misconceptions for Leukemia Patients

If you have a patient with leukemia or hematologic malignancy, but you are unsure if they are eligible for bone marrow transplant, we encourage you...

Research Lab

The Power of Investigator-Initiated Trials

Discover how physician-led clinical trials at Moffitt are driving cancer breakthroughs and giving more patients access to promising new therapies.

Specialized Clinic for Bone Lesions and Bone Metastasis

The Sarcoma Program at Moffitt Cancer Center recently unveiled a new Bone Metastasis Clinic, a first of its kind in Florida and among only a handful...

Multiple Myeloma cells

Understanding MGUS: Why Early Monitoring Can Be Life-Changing

Mal Heme, Malignant Hematology, high-risk, patients Monoclonal Gammopathy of Undetermined Significance (MGUS)

From Clinical Trial to Standard of Care: Pembrolizumab Plus Chemoradiotherapy Available at Moffitt

The introduction of immunotherapy into the curative-intent setting has prompted a meaningful shift in cervical cancer treatment.

Now Enrolling: Novel Dendritic Cell Vaccines Immunotherapy Trial For HER2+ Breast Cancer

Dendritic cell vaccines study offers hope for a less toxic, more personalized approach for the treatment of HER2 breast cancer with less chemotherapy...

a person is scratching a rash on their arm

One of Only Five Multidisciplinary Cutaneous Lymphoma Clinics in U.S. is at Moffitt

Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders that present in the skin and are composed of malignant clonal T- or...

Dr. Vernon Sondak in the surgery room at Moffitt

Q&A: Understanding Intralesional and Infusional Therapies for Metastatic Melanoma

Dr. Matthew Perez discusses intralesional and infusional therapies for metastatic melanoma.

Dr. Kedar Kirtane with Head and Neck Oncology Program examines patient

Anaplastic Thyroid Cancer: A Rare but Urgent Diagnosis – What Referring Providers Need to Know

Recognizing, diagnosing and directing patients with suspected anaplastic thyroid cancer to multidisciplinary teams for timely and effective...

Guide on When to Refer Patients to the Endocrine Oncology Clinic at Moffitt

Moffitt's Endocrine Oncology Program offers a multidisciplinary approach to managing both common and rare endocrine tumors.

Dr. Patrick Hwu and a researcher in immunotherapy lab

SONIC: Specialized Care for Immunotherapy Patients

Moffitt's SONIC program provides specialized care during the first cycles of bispecific antibodies when side effects and adverse events are most...

New FDA-Approved alloHSCT Options for AML Patients Now Available at Moffitt Cancer Center

Newly FDA-approved treosulfan combined with fludarabine as a preparative regimen for alloHSCT.

Sentinel Lymph Node Mapping for Uterine Cancer

Gynecologic oncologists at Moffitt Cancer Center are performing sentinel lymph node (SLN) mapping as a less-invasive alternative for uterine cancer...

Computer generated profile image of the brain

A Primary Care Guide to Early Intervention For Brain Masses

When primary care providers and their patients face the complexity of a brain tumor diagnosis, Moffitt Cancer Center offers unparalleled expertise...